The Affymetrix Alumni: Where Are They Now?

Lori Ciano, executive coach and consultant

Paul Ciccolella, director of SMRT cell manufacturing engineering, PacBio

Paco Cifuentes, director of product applications, Ion Torrent Systems

Jane Clarke, director of US sales at m2p-Labs

Francois Collin, senior statistician, Genomic Health

Jim Collins, biotechnology R&D leader

Grace Colon, president of industrial products division, senior vice president, Intrexon

Wes Conard, communications director, Ion Torrent Systems (part of Life Technologies)

Karen Considine, senior manager, market development, Life Technologies

Beth Concaugh, regional opportunity manager, The Jackson Laboratory

Patrick Cooke, director, FAS, PacBio

Trena Cormier, product marketing manager, NuGEN Technologies

Philippe Cotrel, commercial director, Abcam

Brady Cowden, director, Computime Equity Ventures

Dave Craford, chief of commercial operations, Pathwork Diagnostics

Maureen Cronin, senior vice president of R&D, Foundation Medicine

Dennise Dalma Weiszhausz, founder, Accurine

Mark Daly, account manager, west coast, Complete Genomics

Alan Dance, vice president of marketing, NuGEN Technologies

Steven Daniel, senior director of sales and business development, AltheaDx

Pete Dansky, president of molecular and cell biology, Life Technologies

James Davies, senior manager, HR systems strategy, LinkedIn

Jonathan Day, director of sales in North America, NextGen qPCR technical sales specialists, Life Technologies

Eric De Biasi, senior field service engineer, Leica Microsystems

Gianfranco DeFeo, senior director of marketing, Sequenom

Emmanuel Demillecamps, sales director RAS France, Roche Diagnostics

Tarangini (Gini) Deshpande, co-founder, NuMedii

John Diekman, managing partner, 5AM Ventures

Cindy Dolan, senior sales representative, Ion Torrent Systems

Kurt Donner, protein specialist, ProteinSimple

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.